Skip to main content
Search

Columbia University Irving Medical Center

4 related articles

Subscribe to updates
  1. Medical contrastive learning stops forcing invariance: ProbSSL models embeddings as distributions and reaches 84.89 mean Dice on BTCV

    Medical self-supervised contrastive learning assumes two augmented views of the same image should share one semantic representation, but rotation and intensity perturbations can erase subtle yet critical anatomical and pathological cues, so rigid alignment suppresses task-relevant information. ProbSSL models each image embedding as a Gaussian, with the mean carrying shared semantics and the variance recording augmentation-induced variability, and aligns distributions by KL divergence so dimensions with larger variability receive weaker alignment pressure. After pre-training on CT, transfer to BTCV, MM-WHS, CC-CCII and BraTS gives higher average scores than the compared general and medical self-supervised methods on all four downstream tasks, including 84.89 mean Dice on BTCV.

  2. Using OCD as its example, a review argues that big data in psychiatry must separate etiology from pathophysiology and stay hypothesis-driven to answer a specific disorder's three core questions

    This review, using obsessive-compulsive disorder (OCD) as its example, surveys the advances and constraints of big data approaches to three questions—what causes the disorder, which treatments work best for whom, and how to widen access to evidence-based care—reporting that large-scale pooled data such as ENIGMA-OCD show some previously reported effects to be small but reproducible while others do not replicate at scale or appear to be medication effects, that the Global OCD Study harmonized methods across five international sites and recruited 250 unmedicated adults with OCD and 250 matched healthy volunteers and found relatively few case-control brain differences but more informative associations between specific brain and cognitive measures and OC clinical profiles, and that big data ar

  3. A 45-member modified Delphi consensus: screen for eating disorders before GLP-1 receptor agonist prescribing, and generally avoid these agents in active anorexia and bulimia nervosa

    Using a three-round modified Delphi method, a 45-member panel of clinicians and researchers in diabetes, obesity and/or eating disorders plus people with lived experience reached an average 91.7% consensus on recommendations for GLP-1 receptor agonist use in eating disorder contexts, covering pre-treatment screening, risk-stratified monitoring, standardized educational materials and concurrent evidence-based psychotherapy, stating that these agents should generally be avoided in active eating disorders, particularly anorexia nervosa, atypical anorexia nervosa and bulimia nervosa with marked dietary restraint and/or significant weight suppression, and setting out research priorities in epidemiology, regulation and binge eating disorder trials.

  4. bioRxiv

    RNASeek uses a 1.6B-parameter cross-phyla transcriptomic model for RNA function prediction and GRPO-guided design, yielding ribozymes at wild-type activity and 3′ UTRs beyond the training data

    The authors present RNASeek, a 1.6-billion-parameter generative foundation model built on a DeepSeek architecture and trained on a cross-phyla transcriptomic corpus, using natural-language tokens for conditional prediction and sequence design; it captures species-specific transcript features and intron–exon boundaries in a zero-shot setting, can be fine-tuned to predict ribozyme self-cleavage activity and viral mRNA stability while revealing interpretable features such as loop flexibility, stem stability, and AU-rich motifs, and these functional predictors then serve as reward models for GRPO updates to the generation policy, producing faster-cleaving ribozymes and stability-enhancing 3′ UTRs under user-specified IUPAC constraints, with experimentally validated generated ribozymes reaching

You’re all caught up